Trump Ties Medicare Drug Cost to Rates Paid by Other Nations
- New policy won’t start until Aug. 24 to account for drugmakers
- President also wants EpiPen, insulin discounts passed on
Donald Trump speaks during an executive order signing ceremony on lowering drug prices, in Washington, D.C. on July 24.
Photographer: Stefani Reynolds/BloombergThis article is for subscribers only.
President Donald Trump announced new policies Friday aimed at lowering prescription drug prices under Medicare by linking them to rates paid in other countries and allowing Americans to buy medication imported from Canada.
The changes are included in executive orders that come as Trump seeks to repair his standing on health-care issues, particularly with senior voters. Polls have shown sentiment is souring over his handling of the coronavirus pandemic and efforts to eliminate the Affordable Care Act without having a ready replacement.